.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Novel PI3K Inhibitors in B-Cell Malignancies

EP. 1: Treating Chronic Lymphocytic Leukemia

June 29th 2016

EP. 2: Role of PI3K-Targeted Therapy in CLL

June 29th 2016

EP. 3: Duvelisib in Relapsed/Refractory CLL

June 29th 2016

EP. 4: Encouraging Early Data for Novel PI3K Inhibitors

June 29th 2016

EP. 5: Treatment of Follicular Lymphoma

June 29th 2016

EP. 6: PI3K-Targeted Therapy for Follicular Lymphoma

June 29th 2016

EP. 7: Preliminary Data for Duvelisib in Indolent NHL

June 29th 2016